AlphaVax 
Welcome,         Profile    Billing    Logout  
 4 Products   0 Diseases  4 Products   2 Trials   38 News 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AVX-701 / AlphaVax
SAFYR, NCT06998004: A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

Recruiting
1
144
Europe
AVX70120 low dose level, AVX70120 middle dose level, AVX70120 high dose level, AVX70481 low dose level, AVX70481 middle dose level, AVX70481 high dose level, Placebo
AstriVax Therapeutics
Yellow Fever, Rabies
03/26
03/26
AVX901 / AlphaVax
NCT03632941: A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Active, not recruiting
2
8
US
VRP-HER2, AVX901, Pembrolizumab, Keytruda
Herbert Lyerly, Merck Sharp & Dohme LLC
Breast Cancer, HER2+ Breast Cancer
10/23
12/25
AVX101 / AlphaVax
OFELIA, NCT05073133: Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)

Completed
4
16
RoW
OAV101, AVXS-101, Zolgensma
Novartis Pharmaceuticals
Muscular Atrophy, Spinal
08/23
08/23
2023-000864-67: Safety and efficacy of intravenous OAV101 (AVXS-101) in pediatric patients with spinal muscular atrophy (SMA)

Not yet recruiting
4
16
RoW
Solution for injection, Zolgensma
NOVARTIS BIOCIÊNCIAS S.A, Novartis Pharma AG
Spinal Muscular Atrophy, Spinal Muscular Atrophy, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
 
 
AVX601 / AlphaVax, GSK
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AVX-701 / AlphaVax
SAFYR, NCT06998004: A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

Recruiting
1
144
Europe
AVX70120 low dose level, AVX70120 middle dose level, AVX70120 high dose level, AVX70481 low dose level, AVX70481 middle dose level, AVX70481 high dose level, Placebo
AstriVax Therapeutics
Yellow Fever, Rabies
03/26
03/26
AVX901 / AlphaVax
NCT03632941: A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Active, not recruiting
2
8
US
VRP-HER2, AVX901, Pembrolizumab, Keytruda
Herbert Lyerly, Merck Sharp & Dohme LLC
Breast Cancer, HER2+ Breast Cancer
10/23
12/25
AVX101 / AlphaVax
OFELIA, NCT05073133: Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)

Completed
4
16
RoW
OAV101, AVXS-101, Zolgensma
Novartis Pharmaceuticals
Muscular Atrophy, Spinal
08/23
08/23
2023-000864-67: Safety and efficacy of intravenous OAV101 (AVXS-101) in pediatric patients with spinal muscular atrophy (SMA)

Not yet recruiting
4
16
RoW
Solution for injection, Zolgensma
NOVARTIS BIOCIÊNCIAS S.A, Novartis Pharma AG
Spinal Muscular Atrophy, Spinal Muscular Atrophy, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
 
 
AVX601 / AlphaVax, GSK
No trials found

Download Options